iA Global Asset Management Inc. Acquires 29,368 Shares of HCA Healthcare, Inc. $HCA

iA Global Asset Management Inc. increased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 278.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,928 shares of the company’s stock after purchasing an additional 29,368 shares during the quarter. iA Global Asset Management Inc.’s holdings in HCA Healthcare were worth $15,296,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also bought and sold shares of the company. Cheviot Value Management LLC purchased a new position in shares of HCA Healthcare during the first quarter valued at approximately $26,000. Saudi Central Bank purchased a new position in shares of HCA Healthcare during the first quarter valued at approximately $26,000. WPG Advisers LLC purchased a new position in shares of HCA Healthcare during the first quarter valued at approximately $27,000. Ameriflex Group Inc. purchased a new position in shares of HCA Healthcare during the second quarter valued at approximately $27,000. Finally, Chung Wu Investment Group LLC purchased a new position in HCA Healthcare in the 2nd quarter worth approximately $27,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

NYSE:HCA opened at $460.11 on Friday. The firm has a market capitalization of $107.66 billion, a price-to-earnings ratio of 17.79, a price-to-earnings-growth ratio of 1.38 and a beta of 1.40. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $478.19. The business has a fifty day moving average price of $421.11 and a 200-day moving average price of $386.84.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.HCA Healthcare’s revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the business posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio is 11.13%.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.30% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Oppenheimer boosted their price objective on shares of HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a report on Monday, October 27th. Barclays boosted their price objective on shares of HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a report on Monday, October 27th. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a report on Monday, October 27th. Royal Bank Of Canada boosted their target price on shares of HCA Healthcare from $449.00 to $482.00 and gave the company an “outperform” rating in a research note on Monday, October 27th. Finally, Wells Fargo & Company boosted their target price on shares of HCA Healthcare from $375.00 to $412.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 7th. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $473.53.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.